
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuroendocrine neoplasms of the small intestine and the appendix — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita cienkiego i wyrostka robaczkowego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
Tomasz Bednarczuk, Anna Zemczak, Marek Bolanowski, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 549-583
Open Access | Times Cited: 11
Tomasz Bednarczuk, Anna Zemczak, Marek Bolanowski, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 549-583
Open Access | Times Cited: 11
Showing 11 citing articles:
European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours
Ángela Lamarca, Detlef K. Bartsch, Martyn Caplin, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 9
Open Access | Times Cited: 17
Ángela Lamarca, Detlef K. Bartsch, Martyn Caplin, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 9
Open Access | Times Cited: 17
Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zaleceń ogólnych dotyczących postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
Beata Kos‐Kudła, Wanda Fołtyn, Anna Malczewska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 387-454
Open Access | Times Cited: 35
Beata Kos‐Kudła, Wanda Fołtyn, Anna Malczewska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 387-454
Open Access | Times Cited: 35
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
Paweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5542-5542
Open Access | Times Cited: 21
Paweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5542-5542
Open Access | Times Cited: 21
Prevalence of second primary malignancies in patients with well-differentiated neuroendocrine tumors
Kosma Woliński, Paweł Komarnicki, Adam Maciejewski, et al.
Endocrine Practice (2025)
Closed Access
Kosma Woliński, Paweł Komarnicki, Adam Maciejewski, et al.
Endocrine Practice (2025)
Closed Access
The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors
Özgür Mete, David W. Dodington, Daniel L. Shen, et al.
Endocrine Pathology (2024) Vol. 35, Iss. 2, pp. 107-112
Open Access | Times Cited: 2
Özgür Mete, David W. Dodington, Daniel L. Shen, et al.
Endocrine Pathology (2024) Vol. 35, Iss. 2, pp. 107-112
Open Access | Times Cited: 2
Discussion on the benefits of different treatment strategies in elderly and non-elderly patients with appendix MiNEN: a retrospective study based on SEER database
Xiaoyang Xing, Yongyan Zhang, Liwei Wang, et al.
International Journal of Colorectal Disease (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 6
Xiaoyang Xing, Yongyan Zhang, Liwei Wang, et al.
International Journal of Colorectal Disease (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 6
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
Paweł Komarnicki, Paweł Gut, Jan Musiałkiewicz, et al.
Endocrine Connections (2023) Vol. 12, Iss. 10
Open Access | Times Cited: 4
Paweł Komarnicki, Paweł Gut, Jan Musiałkiewicz, et al.
Endocrine Connections (2023) Vol. 12, Iss. 10
Open Access | Times Cited: 4
The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
Monika Wójcik-Giertuga, Anna Malczewska, Beata Kos‐Kudła
Cancers (2023) Vol. 15, Iss. 22, pp. 5477-5477
Open Access | Times Cited: 2
Monika Wójcik-Giertuga, Anna Malczewska, Beata Kos‐Kudła
Cancers (2023) Vol. 15, Iss. 22, pp. 5477-5477
Open Access | Times Cited: 2
Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine
Tomasz Krzysztof Bryś, Violetta Rosiek, Beata Rembielak-Stawecka, et al.
Endokrynologia Polska (2023) Vol. 74, Iss. 6
Open Access | Times Cited: 2
Tomasz Krzysztof Bryś, Violetta Rosiek, Beata Rembielak-Stawecka, et al.
Endokrynologia Polska (2023) Vol. 74, Iss. 6
Open Access | Times Cited: 2
Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
Violetta Rosiek, Ksenia Janas, Beata Kos‐Kudła
Biomedicines (2023) Vol. 11, Iss. 3, pp. 842-842
Open Access | Times Cited: 1
Violetta Rosiek, Ksenia Janas, Beata Kos‐Kudła
Biomedicines (2023) Vol. 11, Iss. 3, pp. 842-842
Open Access | Times Cited: 1
Novel radiopharmaceuticals in endocrinology: a comprehensive review
Mateusz Pocięgiel, Tomasz Saniewski, Karol Wrzosek, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 617-629
Open Access
Mateusz Pocięgiel, Tomasz Saniewski, Karol Wrzosek, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 617-629
Open Access